slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,531-28,560
Pages 10,126
Rows per page 30
Component
28,531-28,560 of 303,780
35
The slide uses direct quotes from social media to build a case against the product's efficacy and patient experience.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
37
Uses graphic imagery and patient testimonials to frame the company's product as dangerous and the medical practice as profit-driven.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
38
The slide uses anecdotal evidence (patient social media posts) to frame the company's product as a 'hustle' or 'quackery'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
39
The slide uses screenshots of Facebook posts to build a narrative of corporate negligence and product failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
40
The slide uses anecdotal evidence from Facebook support groups to build a negative narrative about the company's product performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
41
The slide uses a combination of analyst commentary and a direct testimonial to frame the company as a 'one-trick pony' in decline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
42
The slide uses strong, accusatory language typical of activist short reports.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
43
The slide uses a strong 'expose contradiction' narrative, contrasting company claims with KOL interviews and clinical studies.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
44
This slide is part of an activist short report, focusing on product failure and management deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
45
This is an activist short-seller report slide. It uses anecdotal evidence from KOLs to build a narrative of systemic failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
46
This slide uses strong, accusatory language typical of activist short-seller reports to frame the company's culture and market position.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
47
This slide uses qualitative evidence from KOLs and ex-employees to build a narrative of corporate failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
48
The slide uses strong, aggressive language to discredit the company's product claims and growth strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
49
This is a text-heavy slide summarizing negative findings from expert interviews (KOLs and former executives).Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
50
The slide uses anecdotal evidence from former executives to build a bearish case against Nevro's turnaround and acquisition potential.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The StruggleLoop · Cost Of Inaction2 hits
51
This slide uses aggressive, activist-style language to frame Nevro as a failing company and Saluda as a disruptive competitor.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
52
The slide uses strong, accusatory language typical of activist short reports to frame the company's business model as fundamentally broken.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
53
The slide uses strong, accusatory language to frame the company's business model as legally compromised.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
54
This is a classic activist short-seller slide designed to frame the company's business model as inherently fraudulent and legally precarious.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
55
This slide focuses on the legal/ethical risk of reps performing clinical duties.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
57
The slide uses a combination of academic citation and visual data to frame the study as potentially fraudulent.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
58
Uses excerpts from a press release and a clinical paper to highlight study design flaws.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
59
The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
60
Uses direct quotes to undermine the credibility of the company's primary clinical evidence.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
61
The slide uses highlighted text to emphasize key accusations regarding the validity of the 10kHz frequency and the integrity of the clinical trial data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
63
The slide uses yellow highlighting to emphasize key accusations of trial manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
64
The slide uses highlighted text to emphasize key accusations of study manipulation and corruption.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
65
The slide uses anecdotal evidence from public review sites to attack the character of a key study investigator.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
66
The slide uses a series of pull-quotes to build a narrative of fraud, specifically highlighting the 'cherry-picking' of patients to skew study results.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
68
The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits